Announcement of Prospectus Publication
“ALPHA TRUST ANDROMEDA Investment Trust S.A” (the "Company") announces that, as of 15.07.2022, makes available to investors the prospectus approved by the Board of Directors of the Hellenic Capital Market Commission on 14.07.2022, which was drafted in accordance with Regulation (EU) 2021/337 amending Regulation (EU) 2017/1129 as regards the EU Recovery prospectus, Regulation (EU) 2017/1129, delegated Regulations (EU) 2019/979 and 2019/980 and Greek Law 4706/2020, as in force (the "Prospectus").
The Prospectus relates to the public offering of 2,406,816 new, common, dematerialised, registered, voting shares, with a nominal value of € 3.4375 each (the "New Shares"), which shall be issued by the Company in the context of its share capital increase through payment in cash, and with a pre‐emptive right in favour of the existing shareholders at a ratio of three (3) New Shares for two (2) existing shares of the Company (the "Share Capital Increase"), at a subscription price of € 6.34 per each New Share, and be admitted to trading on the Regulated Securities Market of the Athens Stock Exchange (the "ATHEX"), in accordance with the decision of the Board of Directors of the Company, dated 12.07.2022, pursuant to the provision of article 24 par. 1(b) of Law 4548/2018, by virtue of the authority granted to the Board of Directors by the Extraordinary General Meeting of the Company’s shareholders dated 25.02.2022.
Information about the procedure for the exercise by investors of the pre‐emptive and presubscription right is set out in section 13.3 "Procedure of exercise of the pre‐emptive rights and the Pre‐subscription Right" of the Prospectus.
The expected timeline for the completion of the Share Capital Increase and the admission of the New Shares to trading is the following:
DATE |
STEP |
14.07.2022 |
Prospectus approval by the Board of Directors of the Hellenic Capital Market Commission |
15.07.2022 |
Publication of the prospectus at the Athex website, Hellenic Capital Market Commission website and the company’s website |
15.07.2022 |
Approval of the admission of the pre-emption rights to trading by the Athens Exchange’s Corporate Actions Committee * |
15.07.2022 |
Publication of the announcement regarding the cut off date of the pre-emption rights and the period for the exercise and trading of the pre-emption rights and the exercise of the subscription rights at the Athens Exchange Daily Bulletin |
18.07.2022 |
Last trading day of the shares with pre-emption rights |
19.07.2022 |
Cutoff date of the pre-emption rights – Adjustment of the share price |
20.07.2022 |
Record date |
21.07.2022 |
Crediting (by the Greek Central Securities Depository SA) of the pre-emption rights to the beneficiaries’ accounts with the D.S.S |
22.07.2022 |
Commencement of the exercise period , the trading period of the pre-emption rights and the exercise of the subscription rights |
01.08.2022 |
End of trading of the pre-emption rights (last day) |
04.08.2022 |
End of the exercise period of pre-emption and subscription rights |
05.08.2022 |
Certification of payment of the Share Capital Increase by the Company’s Board of Directors |
05.08.2022 |
Publication of the announcement regarding the coverage of the Share Capital Increase deriving from the exercise of rights and the potential existence of unallotted shares at the Athex Daily Bulletin and website and at the company’s website |
09.08.2022 |
Approval of the admission to trading of the New Shares by the Athex Listings and Market Operation Committee* |
09.08.2022 |
Publication of the announcement regarding the approval of the admission of the New Shares and the date of the commencement of trading of the New Shares at the Athex Daily Bulletin and website and the company’s website |
11.08.2022 |
Commencement of trading of the New Shares deriving from the Share Capital Increase |
*Subject to the competent ATHEX committee meeting on that date.
It is noted that the above timeline is dependent upon several unforeseeable factors and is subject to change. In any case, investors will be informed through a relevant announcement of the Company.
The Prospectus, as approved by the Board of Directors of the Hellenic Capital Market Commission on 14.07.2022, will be available to investors, in accordance with article 21, par.2 of Regulation (EU) 2017/1129, as in force, in electronic form on the following websites:
- ATHEX ( https://www.athexgroup.gr/el/companies-information-%20memorandum-informative-material)
- Hellenic Capital Market Commission: ( http://www.hcmc.gr/el_GR/web/portal/elib/deltia), and
- Company ( https://www.andromeda.eu/anakoinoseis-oles/auxisi-metohikou-kefalaiou-2022/)
Furthermore, the Prospectus will be available to investors free of charge and in printed copies, if requested, at the Company’s offices, at 17, T.Kavalieratou str. , 145 64, Kifisia.
For more information, investors may contact during the working days and hours the Investor Relations Unit of the Company (Mrs. Maria Marina Printsiou, tel. 210-6289349).
Κifisia, 15 July 2022